Literature DB >> 6341180

Bacteroides fragilis, Streptococcus intermedius and group B streptococci in ascending infection of pregnancy. An animal experimental study.

G Evaldson, A S Malmborg, C E Nord, K Ostensson.   

Abstract

By means of bacteriological, histological and immunofluorescence methods, the ascending spread of endocervically inoculated bacteria was studied in 14 pregnant sheep. 8 ewes near term were exposed to group B streptococci, Bacteroides fragilis or Streptococcus intermedius for 2-4 days. 6 other animals in mid pregnancy were exposed to one of the bacteria mentioned for 30 days. Before inoculation, aerobic and anaerobic culture specimens from cervix and amniotic fluid were obtained. At delivery by caesarean section, in addition to culture specimens, membrane and placental tissues were collected. Bacterial detection by means of indirect immunofluorescence showed significant invasion of the membranes and the placentas by the microorganisms inoculated. In one case, inoculated with S. intermedius, the ascending infection could be shown to pass the intact membranes reaching the amniotic fluid. It is concluded that endocervical bacteria in the indigenous microflora might cause pregnancy complications by establishing ascending infection. Furthermore, as the bacteria tested have been implicated in premature rupture of the membranes, an aetiological role of ascending infection in this pregnancy complication is postulated.

Entities:  

Mesh:

Year:  1983        PMID: 6341180     DOI: 10.1159/000299415

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

Review 1.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 2.  The role of inflammation and infection in preterm birth.

Authors:  Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Juan Pedro Kusanovic; Lara Friel; Sonia Hassan
Journal:  Semin Reprod Med       Date:  2007-01       Impact factor: 1.303

Review 3.  Recurrent preterm birth.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Beth L Pineles; Francesca Gotsch; Pooja Mittal; Nandor Gabor Than; Jimmy Espinoza; Sonia S Hassan
Journal:  Semin Perinatol       Date:  2007-06       Impact factor: 3.300

4.  What is amniotic fluid 'sludge'?

Authors:  R Romero; J P Kusanovic; J Espinoza; F Gotsch; C L Nhan-Chang; O Erez; C J Kim; N Khalek; P Mittal; L F Goncalves; C Schaudinn; S S Hassan; J W Costerton
Journal:  Ultrasound Obstet Gynecol       Date:  2007-10       Impact factor: 7.299

5.  Human beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity.

Authors:  Eleazar Soto; Jimmy Espinoza; Jyh Kae Nien; Juan Pedro Kusanovic; Offer Erez; Karina Richani; Joaquin Santolaya-Forgas; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2007-01

6.  Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes.

Authors:  Offer Erez; Roberto Romero; Adi L Tarca; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Nandor Gabor Than; Edi Vaisbuch; Sorin Draghici; Gerard Tromp
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

7.  Virulence of human and bovine isolates of group B streptococci (types Ia and III) in experimental pregnant mouse models.

Authors:  B Poutrel; J Dore
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

8.  Fetal human keratinocytes produce large amounts of antimicrobial peptides: involvement of histone-methylation processes.

Authors:  Maria Gschwandtner; Shaomin Zhong; Antonia Tschachler; Veronika Mlitz; Susanne Karner; Adelheid Elbe-Bürger; Michael Mildner
Journal:  J Invest Dermatol       Date:  2014-04-02       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.